Literature DB >> 33782920

Theoretical study of the interactions between peptide tyrosine tyrosine [PYY (1-36)], a newly identified modulator in type 2 diabetes pathophysiology, with receptors NPY1R and NPY4R.

Yee Siew Choong1, Yee Ying Lim2, Jia Xin Soong2, Nandini Savoo3, Claudia Guida4, Lydia Rhyman3,5, Reshma Ramracheya6,7, Ponnadurai Ramasami8,9.   

Abstract

PURPOSE: Diabetes mellitus is a common condition in the clinically obese. Bariatric surgery is one of the ways to put type 2 diabetes in remission. Recent findings propose the appetite-regulator peptide tyrosine tyrosine (PYY) as a therapeutic option for patients with type 2 diabetes. This novel gut hormone restores impaired insulin and glucagon secretion in pancreatic islets and is implicated in type 2 diabetes reversal after bariatric surgery. The current study elucidates the interactions between PYY and the NPY1R and NPY4R receptors using computational methods.
METHODS: Protein structure prediction, molecular docking simulation, and molecular dynamics (MD) simulation were performed to elucidate the interactions of PYY with NPY1R and NPY4R.
RESULTS: The predicted binding models of PYY-NPY receptors are in agreement with those described in the literature, although different interaction partners are presented for the C-terminal tail of PYY. Non-polar interactions are predicted to drive the formation of the protein complex. The calculated binding energies show that PYY has higher affinity for NPY4R (ΔGGBSA = -65.08 and ΔGPBSA = -87.62 kcal/mol) than for NPY1R (ΔGGBSA = -23.11 and ΔGPBSA = -50.56 kcal/mol).
CONCLUSIONS: Based on the constructed models, the binding conformations obtained from docking and MD simulation for both the PYY-NPY1R and PYY-NPY4R complexes provide a detailed map of possible interactions. The calculated binding energies show a higher affinity of PYY for NPY4R. These findings may help to understand the mechanisms behind the improvement of diabetes following bariatric surgery.
© 2021. Hellenic Endocrine Society.

Entities:  

Keywords:  Binding energy; Molecular dynamics; NPY1R; NPY4R; PYY

Mesh:

Substances:

Year:  2021        PMID: 33782920     DOI: 10.1007/s42000-021-00278-2

Source DB:  PubMed          Journal:  Hormones (Athens)        ISSN: 1109-3099            Impact factor:   2.885


  36 in total

1.  The Leading Role of Peptide Tyrosine Tyrosine in Glycemic Control After Roux-en-Y Gastric Bypass in Rats.

Authors:  Alonso Camacho-Ramírez; J Arturo Prada-Oliveira; Antonio Ribelles-García; David Almorza-Gomar; Gonzalo M Pérez-Arana
Journal:  Obes Surg       Date:  2020-02       Impact factor: 4.129

2.  The control of diabetes mellitus (NIDDM) in the morbidly obese with the Greenville Gastric Bypass.

Authors:  W J Pories; J F Caro; E G Flickinger; H D Meelheim; M S Swanson
Journal:  Ann Surg       Date:  1987-09       Impact factor: 12.969

Review 3.  The Role of PYY in Pancreatic Islet Physiology and Surgical Control of Diabetes.

Authors:  Claudia Guida; Sam Stephen; Romain Guitton; Reshma D Ramracheya
Journal:  Trends Endocrinol Metab       Date:  2017-05-19       Impact factor: 12.015

4.  Weight-independent changes in blood glucose homeostasis after gastric bypass or vertical sleeve gastrectomy in rats.

Authors:  Adam P Chambers; Lene Jessen; Karen K Ryan; Stephanie Sisley; Hilary E Wilson-Pérez; Margaret A Stefater; Shrawan G Gaitonde; Joyce E Sorrell; Mouhamadoul Toure; Jose Berger; David A D'Alessio; Stephen C Woods; Randy J Seeley; Darleen A Sandoval
Journal:  Gastroenterology       Date:  2011-07-12       Impact factor: 22.682

5.  Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects.

Authors:  S H Jacobsen; S C Olesen; C Dirksen; N B Jørgensen; K N Bojsen-Møller; U Kielgast; D Worm; T Almdal; L S Naver; L E Hvolris; J F Rehfeld; B S Wulff; T R Clausen; D L Hansen; J J Holst; S Madsbad
Journal:  Obes Surg       Date:  2012-07       Impact factor: 4.129

6.  Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes.

Authors:  Blandine Laferrère; Julio Teixeira; James McGinty; Hao Tran; Joseph R Egger; Antonia Colarusso; Betty Kovack; Baani Bawa; Ninan Koshy; Hongchan Lee; Kimberly Yapp; Blanca Olivan
Journal:  J Clin Endocrinol Metab       Date:  2008-04-22       Impact factor: 5.958

Review 7.  The effect of bariatric surgery on gastrointestinal and pancreatic peptide hormones.

Authors:  Claire L Meek; Hannah B Lewis; Frank Reimann; Fiona M Gribble; Adrian J Park
Journal:  Peptides       Date:  2015-09-05       Impact factor: 3.750

8.  Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes.

Authors:  Blandine Laferrère; Stanley Heshka; Krystle Wang; Yasmin Khan; James McGinty; Julio Teixeira; Allison B Hart; Blanca Olivan
Journal:  Diabetes Care       Date:  2007-04-06       Impact factor: 19.112

9.  PYY plays a key role in the resolution of diabetes following bariatric surgery in humans.

Authors:  Claudia Guida; Sam D Stephen; Michael Watson; Niall Dempster; Pierre Larraufie; Thomas Marjot; Tamsin Cargill; Lisa Rickers; Michael Pavlides; Jeremy Tomlinson; Jeremy F L Cobbold; Chun-Mei Zhao; Duan Chen; Fiona Gribble; Frank Reimann; Richard Gillies; Bruno Sgromo; Patrik Rorsman; John D Ryan; Reshma D Ramracheya
Journal:  EBioMedicine       Date:  2019-01-11       Impact factor: 8.143

10.  PYY-Dependent Restoration of Impaired Insulin and Glucagon Secretion in Type 2 Diabetes following Roux-En-Y Gastric Bypass Surgery.

Authors:  Reshma D Ramracheya; Laura J McCulloch; Anne Clark; David Wiggins; Helene Johannessen; Magnus Kringstad Olsen; Xing Cai; Chun-Mei Zhao; Duan Chen; Patrik Rorsman
Journal:  Cell Rep       Date:  2016-04-21       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.